Ledger.Open graph →
SEC Form D · filed June 18, 2014

HYPERION THERAPEUTICS INC

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Brisbane, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christine A. Nash · Brisbane, CAExecDaniel G. Welch · Bothell, WADirectorBo Jesper I. Hansen · Brisbane, CADirectorChristine A. Nash · NEW HAVEN, CTExecNatalie A. Holles · Brisbane, CAExecJake R. Nunn · Brisbane, CADirectorBijan R. Salehizadeh · Brisbane, CADirectorDaniel G. Welch · Brisbane, CADirectorAshley A. Gould · Brisbane, CAExecLota S. Zoth · Clinton, NJDirectorDonald J. Santel · Brisbane, CAExecKlara A. Dickinson · Brisbane, CAExecBruce F. Scharschmidt · Brisbane, CAExecJeffrey S. Farrow · Brisbane, CAExecJames I. Healy · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗